Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07215455 · ClinicalTrials.gov registry record · NA
Ashwagandha Extract for Weight and Stress Management in Overweight and Obese Adults
A NA study of Stress and Weight Management, sponsored by SF Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT07215455: Completed NA study of Stress and Weight Management, sponsored by SF Research Institute.
NCT07215455 is a NA study of Stress and Weight Management that has completed, run by SF Research Institute. The registered enrollment target is 50 participants, below the 786-participant average among 152 other Stress trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07215455, a NA study of Stress and Weight Management, has completed, sponsored by SF Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is designed to evaluate the effects of KSM-66 Ashwagandha root extract (300 mg daily) on weight management and stress reduction in overweight and obese adults. Ashwagandha (Withania somnifera) is a traditional herbal supplement that may help reduce stress and support overall health. In this randomized, double-blind, placebo-controlled trial, participants will receive either Ashwagandha extract or a placebo for the study duration. The main goal is to measure changes in body weight and stress levels. Other health outcomes, such as body mass index (BMI), waist circumference, and quality of life, will also be assessed. The study will help determine whether Ashwagandha is effective and safe for managing stress and supporting weight loss in adults with overweight or obesity.
Primary Outcome
Change from baseline in body weight (kg) and body mass index (BMI, kg/m²) will be assessed in overweight and obese adult participants at Week 4 and Week 12. Measurements will be performed using standardized calibrated equipment under consistent conditions at each visit.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Ashwagandha 300 mg standardized root extract
- OTHER Identical placebo capsule.
Study Locations (1)
California
- San Francisco Research Institute - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-06-17 |
| Est. Completion | 2025-10-22 |
| Phase | NA |
What the finished NCT07215455 record still lists
NCT07215455 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 786-participant average among 152 other Stress trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Stress appearing as the primary indexed condition, and to 2 interventions - of which Ashwagandha 300 mg standardized root extract is the first listed.
NCT07215455 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07215455 about?
NCT07215455 is a clinical study titled "Ashwagandha Extract for Weight and Stress Management in Overweight and Obese Adults". This study is designed to evaluate the effects of KSM-66 Ashwagandha root extract (300 mg daily) on weight management and stress reduction in overweight and obese adults. Ashwagandha (Withania somnifera) is a traditional herbal supplement that may help reduce stress and support overall health. In th...
What is the current status of trial NCT07215455?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2025-06-17. Estimated completion is 2025-10-22.
What conditions does trial NCT07215455 study?
This clinical trial studies the following conditions: Stress, Weight Management.
What interventions are being tested in trial NCT07215455?
The interventions under investigation include: Ashwagandha 300 mg standardized root extract (DIETARY_SUPPLEMENT), Identical placebo capsule. (OTHER).
Who is sponsoring clinical trial NCT07215455?
This trial is sponsored by SF Research Institute, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07215455 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stress
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07215455's enrollment target sits among peer trials
50 107th of 152 higher than 41 of 152 other Stress trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stress trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mindfulness-Based Intervention With a Supplement for Stress-Related Problems in College Students Across Multiple Sites (4SITE)
RECRUITING · NA
-
Digital Intervention for Physical Activity
RECRUITING · NA
-
Cocooned Moms Study
RECRUITING · NA
-
Student Exercise and Sleep Timing Study - Part 2
RECRUITING · NA
-
Smartphone-based Cognitive Emotion Regulation Training for Unpaid Primary Caregivers of Persons With Alzheimer's Disease
RECRUITING · NA
-
ACT for HIV-Positive Men
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI